Skip to main content
. 2011 Jun;52(6):1294–1302. doi: 10.1194/jlr.D014621

TABLE 4.

Relative peak areas of different ceramides during SMase treatment

SMase Treatment (min)
0 15 30 90
% % % %
Ceramide
 d16:1 4.8 6.3 6.6 6.5
 d18:1 81.4 78.4 77.9 79.4
 d20:1 3.0 2.0 2.1 1.9
Dihydroceramide
 d16:0 0.5 0.8 0.8 0.6
 d18:0 5.7 9.5 9.1 7.0
 d20:0 0.3 0.1 0.1 0.1
Phytoceramide
 t16:0 0.2 0.1 0.1 0.1
 t18:0 3.8 2.8 3.3 4.2
 t20:0 0.4 0.1 0.1 0.2